Saiboku-toAlternative Names: TJ 96
Latest Information Update: 13 Aug 2002
At a glance
- Originator Tsumura
- Class Antiallergics; Antiasthmatics; Phytotherapies
- Mechanism of Action Beta-adrenergic receptor agonists; Histamine release inhibitors; Platelet activating factor inhibitors; Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Asthma; Respiratory tract disorders